HGSOC patients with BRCA mutation and homologous recombination deficiency (HRD) were found to exhibit increases in CD3 + /CD8 + tumor-infiltrating lymphocytes (TILs), immunohistochemical staining for PD-1/PD-L1, and neoantigen load. This evidence concerns the gene CD274 and neoplasm.